Human genetics as a model for target validation: finding new therapies for diabetes
Crossref DOI link: https://doi.org/10.1007/s00125-017-4270-y
Published Online: 2017-04-26
Published Print: 2017-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Thomsen, Soren K.
Gloyn, Anna L.
Funding for this research was provided by:
University of Oxford
License valid from 2017-04-26